-
<![CDATA[RAMPART Trial Highlights Kidney Cancer Treatment Options ]]>
18 Nov 2025 03:33 GMT
… about the latest advances in kidney cancer treatment. Their conversation highlighted recent clinical … high-risk kidney cancer.
A major focus was the RAMPART trial, an … of understanding biomarkers, exploring clinical trial options, and seeking second …
-
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter – Hagens Berman
17 Nov 2025 18:55 GMT
… 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a … detect a specific type of kidney cancer. During the Class Period, … lower. Then, another concerning development occurred on August 28, … the drug product used in the phase 3 clinical trial …
-
Unexpected Insights into Wilms Tumour Development
17 Nov 2025 04:27 GMT
… into this enigmatic form of kidney cancer, which primarily affects children. By … methodologies in oncologymechanisms of kidney cancer developmentmultifaceted nature of tumor developmentpersonalized treatment strategies for Wilms …
-
<![CDATA[TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer]]>
15 Nov 2025 03:48 GMT
A real-world study presented at the 2025 International Kidney Cancer Symposium showed that adults with metastatic renal cell carcinoma who previously received one immune checkpoint inhibitor were most often managed with tyrosine kinase inhibitor (TKI)- …
-
<![CDATA[Higher BMI Linked to Better Survival in Localized Kidney Cancer]]>
15 Nov 2025 03:48 GMT
Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell carcinoma (RCC), while significant weight loss predicts poorer prognosis, according to study findings presented in a poster session at …
-
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter – Hagens Berman
14 Nov 2025 18:55 GMT
… (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a … detect a specific type of kidney cancer. During the Class Period, … lower. Then, another concerning development occurred on August 28, … the drug product used in the phase 3 clinical trial and …
-
TKT Fuels Renal Cancer via Metabolic Synergy
18 Nov 2025 19:57 GMT
… forms of kidney cancer, has long eluded effective treatments due to … and patient prognosis. Developing non-invasive assays to … the way for rational drug design aimed at … cancer research findingskidney cancer treatment challengesmetabolic flux analysis …
-
A Case of Recurrent Multiple Uterine Fibroids Associated with Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC): Insights into Fumarate Hydratase (FH) Deficiency
18 Nov 2025 18:46 GMT
… and robotic radical nephrectomy for kidney cancer on October 14, 2024.
… It is characterized by the development of multiple tumor types, … a family pedigree. Am J Med Sci. 2020;360(6): … consensus on the diagnosis and treatment of fumarate hydratase-deficient …
-
<![CDATA[HIF-2α Inhibitor Combinations Keep Active in Second-Line RCC]]>
18 Nov 2025 04:06 GMT
… evaluating the class of drug in combination with immunotherapy … the phase 3 LITESPARK-005 trial (NCT04195750), which evaluated … As we learn more about kidney cancer biology, it’s clear that … immune checkpoint inhibitor (ICI) treatment in metastatic renal cell …
-
Amazon Scorpion Venom Reveals Powerful Anti-Cancer Molecule Driving New Therapies
18 Nov 2025 10:40 GMT
… redefining next-gen cancer treatment.
A molecule found …
Radiotheranostics: Diagnosing and Treating Tumors in One Step … Institute, researchers are developing personalized cancer vaccines made … trials in melanoma, kidney cancer and glioblastoma show promising …
About
© 1995-2025